Authors:

Márkez R, Montero I.

Subconjuntival application of regenerative factor rich plasma for the treatment of ocular alkali burns.
Eur J Ophthalmol 2009; 19: 909-915

[ See Abstract ]

Authors:

Anitua E, Sanchez M, Merayo Lloves J, De la Fuente M, Muruzabal F, Orive G.

Plasma rich in growth factors (PRGF® – Endoret®) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts while inhibits and reverts TGF-{beta}1-induced myodifferentiation.
Invest Ophthalmol Vis Sci. 2011; 52(9):6066-73

[ See Abstract ]

Authors:

Anitua E, Sánchez M, Orive G.

The importance of understanding what is PRGF and what is not.
J Shoulder and Elbow Surgery 2011, 20, e23-e24

Authors:

Anitua E, Sánchez M, Prado R, Orive G.

The P makes the difference in plasma rich in growth factors (PRGF) technology.
Platelets (In press 2011)

Authors:

Anitua E, Alkhraisat MH, Orive G.

Perspectives and challenges in regenerative medicine using Plasma Rich in Growth Factors.
Journal of Controlled Release (In Press 2011)

[ See Abstract ]

Authors:

López-Plandolit S, Morales MC, Freire V, Etxebarría J, Durán JA.

Plasma Rich in Growth Factors as a Therapeutic Agent for Persistent Corneal Epithelial Defects.
Cornea, 2010; 29(8):843-8.

[ See Abstract ]

Authors:

Anitua E, Sánchez M, Orive G.

Potential of endogenous regenerative technology for in situ regenerative medicine.
Adv Drug Deliv Rev. 2010; 62 (7-8):741-52

[ See Abstract ]

Authors:

Sanchéz M, Anitua E, Andia I.

Poor standardization in platelet-rich therapies hampers advancement.
Arthroscopy, 2010, 26 (6), 725-6

Authors:

Anitua E, Sánchez M, Orive G, Andía I.

Delivering growth factors for therapeutics.
Trends Pharmacol Sci 2008;29:37-41

[ See Abstract ]

Authors:

Alio J.L., Pastor S, Ruiz Colecha J, Rodriguez A, Artola A.

Treatment of ocular surface syndrome after LASIK with autologous platelet rich plasma.
J Refract Surg 2007; 23: 617-619

[ See Abstract ]

Authors:

Germán A Rocha, Arantxa Acera, Juan A Durán

Laser in situ Keratomileusis Flap Necrosis After Trigeminal Nerve Palsy.
Arch Ophtalmol, 2007; 125 (10):1423-1425

[ See Abstract ]

Authors:

Alio J, Abad M, Artola A, L. Rodriguez-Prats J, Pastor S, Ruiz-Colecha J

Use of Autologous Platelet-Rich Plasma in the Treatment of Dormant Corneal Ulcers.
Ophtalmology, 2007; 114 (7): 1286-1293

[ See Abstract ]

Authors:

Alio J, Colecha J, Pastor S, Rodriguez A, Artola A.

Symptomatic Dry Eye Treatment with Autologous Platelet-Rich Plasma
Ophtalmic Res 2007; 39: 124-129

[ See Abstract ]

Authors:

Anitua E, Sánchez M, Orive G, Andía I.

The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.
Biomaterials 2007; 28: 4551-4560.

[ See Abstract ]

Authors:

Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I.

New insights into and novel applications for platelet-rich fibrin therapies.
Trends Biotechnology 2006;5:227-234.

[ See Abstract ]